80 related articles for article (PubMed ID: 11393779)
1. The Src signaling pathway regulates osteoclast lysosomal enzyme secretion and is rapidly modulated by estrogen.
Pascoe D; Oursler MJ
J Bone Miner Res; 2001 Jun; 16(6):1028-36. PubMed ID: 11393779
[TBL] [Abstract][Full Text] [Related]
2. Estrogen modulation of osteoclast lysosomal enzyme secretion.
Kremer M; Judd J; Rifkin B; Auszmann J; Oursler MJ
J Cell Biochem; 1995 Feb; 57(2):271-9. PubMed ID: 7759564
[TBL] [Abstract][Full Text] [Related]
3. Rescue of osteoclast function by transgenic expression of kinase-deficient Src in src-/- mutant mice.
Schwartzberg PL; Xing L; Hoffmann O; Lowell CA; Garrett L; Boyce BF; Varmus HE
Genes Dev; 1997 Nov; 11(21):2835-44. PubMed ID: 9353253
[TBL] [Abstract][Full Text] [Related]
4. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
Michael H; Härkönen PL; Väänänen HK; Hentunen TA
J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
[TBL] [Abstract][Full Text] [Related]
5. Evidence of a correlation of estrogen receptor level and avian osteoclast estrogen responsiveness.
Pederson L; Kremer M; Foged NT; Winding B; Ritchie C; Fitzpatrick LA; Oursler MJ
J Bone Miner Res; 1997 May; 12(5):742-52. PubMed ID: 9144340
[TBL] [Abstract][Full Text] [Related]
6. Estrogen modulation of avian osteoclast lysosomal gene expression.
Oursler MJ; Pederson L; Pyfferoen J; Osdoby P; Fitzpatrick L; Spelsberg TC
Endocrinology; 1993 Mar; 132(3):1373-80. PubMed ID: 8440193
[TBL] [Abstract][Full Text] [Related]
7. Regulation of collagenolytic protease secretion through c-Src in osteoclasts.
Furuyama N; Fujisawa Y
Biochem Biophys Res Commun; 2000 May; 272(1):116-24. PubMed ID: 10872813
[TBL] [Abstract][Full Text] [Related]
8. c-Src activation plays a role in endothelin-dependent hypertrophy of the cardiac myocyte.
Kovacic B; Ilić D; Damsky CH; Gardner DG
J Biol Chem; 1998 Dec; 273(52):35185-93. PubMed ID: 9857056
[TBL] [Abstract][Full Text] [Related]
9. Effect of estradiol on estrogen receptor-alpha gene expression and activity can be modulated by the ErbB2/PI 3-K/Akt pathway.
Stoica GE; Franke TF; Moroni M; Mueller S; Morgan E; Iann MC; Winder AD; Reiter R; Wellstein A; Martin MB; Stoica A
Oncogene; 2003 Sep; 22(39):7998-8011. PubMed ID: 12970748
[TBL] [Abstract][Full Text] [Related]
10. AND-34 activates phosphatidylinositol 3-kinase and induces anti-estrogen resistance in a SH2 and GDP exchange factor-like domain-dependent manner.
Felekkis KN; Narsimhan RP; Near R; Castro AF; Zheng Y; Quilliam LA; Lerner A
Mol Cancer Res; 2005 Jan; 3(1):32-41. PubMed ID: 15671247
[TBL] [Abstract][Full Text] [Related]
11. v-Src and c-Src, nonpalmitoylated Src-family kinases, induce perinuclear accumulation of lysosomes through Rab7 in a kinase activity-independent manner.
Kasahara K; Nakayama Y; Yamaguchi N
Cancer Lett; 2008 Apr; 262(1):19-27. PubMed ID: 18171604
[TBL] [Abstract][Full Text] [Related]
12. Extensive clear zone and defective ruffled border formation in osteoclasts of osteopetrotic (ia/ia) rats: implications for secretory function.
Reinholt FP; Hultenby K; Heinegård D; Marks SC; Norgård M; Anderson G
Exp Cell Res; 1999 Sep; 251(2):477-91. PubMed ID: 10471332
[TBL] [Abstract][Full Text] [Related]
13. Effects of the phytoestrogen coumestrol on RANK-ligand-induced differentiation of osteoclasts.
Kanno S; Hirano S; Kayama F
Toxicology; 2004 Oct; 203(1-3):211-20. PubMed ID: 15363596
[TBL] [Abstract][Full Text] [Related]
14. Src tyrosine kinase mediates stimulation of Raf-1 and mitogen-activated protein kinase by the tumor promoter thapsigargin.
Chao TS; Abe M; Hershenson MB; Gomes I; Rosner MR
Cancer Res; 1997 Aug; 57(15):3168-73. PubMed ID: 9242445
[TBL] [Abstract][Full Text] [Related]
15. Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N; Bastholm L; Kirkegaard-Sørensen T; Rafn B; Bøttzauw T; Nielsen C; Weber E; Shirasawa S; Kallunki T; Jäättelä M
Cancer Res; 2008 Aug; 68(16):6623-33. PubMed ID: 18701486
[TBL] [Abstract][Full Text] [Related]
16. pp59fyn and pp62c-yes are enriched in SH-SY5Y neuroblastoma growth cones but do not associate to the 38 kDa protein which complexes with pp60c src and pp60c-srcN.
Meyerson G; Påhlman S
FEBS Lett; 1993 Oct; 332(1-2):27-30. PubMed ID: 7691658
[TBL] [Abstract][Full Text] [Related]
17. Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells.
Oursler MJ; Pederson L; Fitzpatrick L; Riggs BL; Spelsberg T
Proc Natl Acad Sci U S A; 1994 Jun; 91(12):5227-31. PubMed ID: 8202473
[TBL] [Abstract][Full Text] [Related]
18. Colony-stimulating factor-1 induces cytoskeletal reorganization and c-src-dependent tyrosine phosphorylation of selected cellular proteins in rodent osteoclasts.
Insogna KL; Sahni M; Grey AB; Tanaka S; Horne WC; Neff L; Mitnick M; Levy JB; Baron R
J Clin Invest; 1997 Nov; 100(10):2476-85. PubMed ID: 9366562
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of osteoclast differentiation by daidzein via caspase 3.
Rassi CM; Lieberherr M; Chaumaz G; Pointillart A; Cournot G
J Bone Miner Res; 2002 Apr; 17(4):630-8. PubMed ID: 11918220
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin inhibits osteoclast differentiation induced by bone morphogenetic protein-2 and RANKL through regulating MAPK, AKT and Src signaling.
Yamashita M; Otsuka F; Mukai T; Yamanaka R; Otani H; Matsumoto Y; Nakamura E; Takano M; Sada KE; Makino H
Regul Pept; 2010 Jun; 162(1-3):99-108. PubMed ID: 20346376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
